The FDA has approved Kedrion Biopharma’s Qivigy, a 10% IV immunoglobulin therapy, for treating adults who have primary ...
News-Medical.Net on MSN
How shifting antibodies fuel aging and the new therapies aiming to slow it
This review uncovers how aging reshapes immunoglobulins, particularly IgG, IgM, and IgA, driving inflammation, cellular senescence, and tissue degeneration. By dissecting B-cell dysfunction, ...
Kelley L. Julian, PharmD, BCOP, discusses optimizing myeloma care, addressing barriers in access to intravenous ...
IgA nephropathy has a complex hereditary pattern. You may not develop it unless you inherit multiple risk genes and also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results